These observations are also in good correlation with the intratumoral expression pattern and activity of AHR and PXR that are downregulated with the progression of the disease, or were lower in aggressive, highly proliferative, and undifferentiated breast cancer cases. Here, NR1I2 is linked to breast carcinoma.